At PCORI, we take a unique approach to funding comparative clinical effectiveness research-ensuring that we focus on outcomes important to patients and that patients and others across the healthcare community have a meaningful role in guiding our work. Patients and other stakeholders help us determine which research topics we consider funding and help us review proposals. We also require that patients are included as meaningful partners in the research we support, helping to develop and conduct the studies and disseminate the results.
We call this "research done differently. We're committed to this approach because we believe strongly that it will focus the research we fund on producing useful information that can answer the questions of greatest importance to patients and those who care for them.
Of course, as we're a young and still-growing research organization, a major question remains: will our approach yield the results we strive to achieve? As proponents of evidence-based practice, we're eager to find out the extent to which this research leads to more-useful healthcare information. So we're pleased to announce the formation of the PCORI Evaluation Group, a task force that will advise PCORI on how best to measure and evaluate the effectiveness of our work, from the usefulness of the studies we fund, to the extent to which the findings from these studies affect health decisions.
The task force includes members of our Board of Governors and Methodology Committee, PCORI staff, and four external advisors selected based on their expertise in specific areas of evaluation research. – less – More from ZoomInfo »